Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 1/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 7/20 | 0.35 |
| ▸ | CA2 | P00918 | 7/20 | 0.35 |
| ▸ | CA9 | Q16790 | 7/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA3 | P07451 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21357864 | 1.00 | ODC1 (0.60) | ODC1ADRB2ADRB1ADRB3IDO1 | |
| SCHEMBL21357744 | 1.00 | ODC1 (0.60) | ODC1ADRB2ADRB1ADRB3IDO1 | |
| SCHEMBL9185840 | 1.00 | — | — | |
| SCHEMBL10776208 | 1.00 | ODC1 (0.60) | ODC1ADRB2ADRB1ADRB3IDO1 | |
| SCHEMBL756020 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL9191751 | 0.91 | — | — | |
| SCHEMBL755068 | 0.86 | — | — | |
| SCHEMBL22895260 | 0.86 | ODC1 (0.75) | ODC1ADRB2ADRB1ADRB3CA1 | |
| SCHEMBL10800049 | 0.86 | ODC1 (0.75) | ODC1ADRB2ADRB1ADRB3CA1 | |
| SCHEMBL4068272 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350609-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2024-10-24 | — | — | US | claimed |
| EP-4450082-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | Serum Institute Of India Private Limited (IN) | 2024-10-23 | — | — | EP | claimed |
| US-20230183765-A1 | METHODS FOR SIMULTANEOUS FRAGMENTATION AND PURIFICATION OF BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2023-06-15 | — | — | US | claimed |
| EP-4150104-A1 | METHODS FOR SIMULTANEOUS FRAGMENTATION AND PURIFICATION OF BACTERIAL POLYSACCHARIDES | Serum Institute Of India Private Limited (IN) | 2023-03-22 | — | — | EP | claimed |
| EP-4025246-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Serum Institute Of India Private Limited (IN) | 2022-07-13 | — | — | EP | claimed |
| CN-114728053-A | Immunogenic compositions against intestinal disease and process for preparing same | 印度血清研究所私人有限公司 | 2022-07-08 | — | — | CN | claimed |
| EP-2513056-B1 | CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES | SERUM INST OF INDIA PVT LTD (IN) | 2022-05-04 | — | — | EP | claimed |
| WO-2021229604-A1 | METHODS FOR SIMULTANEOUS FRAGMENTATION AND PURIFICATION OF BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-11-18 | — | — | WO | claimed |
| WO-2021044436-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | WO | claimed |
| US-20210070890-A1 | METHOD FOR OBTAINING PURIFIED BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | US | claimed |
| EP-3789494-A1 | METHOD FOR OBTAINING PURIFIED BACTERIAL POLYSACCHARIDES | Serum Institute of India Private Limited (IN) | 2021-03-10 | — | — | EP | claimed |
| US-9259480-B2 | Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-CBT), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS LLC (US) | 2016-02-16 | — | — | US | claimed |
| US-9254337-B2 | Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2H)-one (2-CPO), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2016-02-09 | — | — | US | claimed |
| US-9248197-B2 | Activation of polysaccharides via the cyanylating agent, 1-cyanoimidazole (1-Cl), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2016-02-02 | — | — | US | claimed |
| CN-102892753-B | Chemical agents for activating polysaccharides in the preparation of conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2016-01-20 | — | — | CN | claimed |
| US-9044517-B2 | Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2015-06-02 | — | — | US | claimed |
| EP-0516074-B1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER CHEMIE GMBH (DE) | 1995-09-27 | — | — | EP | claimed |
| US-5278225-A | Comprising (meth)acrylates of alcohol monomer | WACKER-CHEMIE GMBH (DE) | 1994-01-11 | — | — | US | claimed |
| EP-0516074-A1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER-CHEMIE GMBH (DE) | 1992-12-02 | — | — | EP | claimed |
| US-12497640-B2 | Methods for simultaneous fragmentation and purification of bacterial polysaccharides | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-12-16 | — | — | US | disclosed |
| US-12473379-B2 | Method for obtaining purified bacterial polysaccharides | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-11-18 | — | — | US | disclosed |
| EP-4605412-A1 | METHOD FOR MANUFACTURING RECOMBINANT TRANSFERRIN BINDING PROTEINS AND VACCINE COMPOSITIONS COMRPISING SAME | Serum Institute of India Pvt. Ltd. (IN) | 2025-08-27 | — | — | EP | disclosed |
| US-20250134980-A1 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-05-01 | — | — | US | disclosed |
| US-20240350609-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2024-10-24 | — | — | US | disclosed |
| EP-4450082-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | Serum Institute Of India Private Limited (IN) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024084497-A1 | METHOD FOR MANUFACTURING RECOMBINANT TRANSFERRIN BINDING PROTEINS AND VACCINE COMPOSITIONS COMRPISING SAME | SERUM INSTITUTE OF INDIA PVT. LTD., (IN) | 2024-04-25 | — | — | WO | disclosed |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| EP-4249061-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Serum Institute Of India Private Limited (IN) | 2023-09-27 | — | — | EP | disclosed |
| US-20230183765-A1 | METHODS FOR SIMULTANEOUS FRAGMENTATION AND PURIFICATION OF BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2023-06-15 | — | — | US | disclosed |
| US-20230149524-A1 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2023-05-18 | — | — | US | disclosed |
| WO-2023069278-A1 | CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES | FINA BIOSOLUTIONS, LLC (US) | 2023-04-27 | — | — | WO | disclosed |
| US-20230122876-A1 | Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines | FINA BIOSOLUTIONS, LLC (US) | 2023-04-20 | — | — | US | disclosed |
| US-20230100885-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-03-30 | — | — | US | disclosed |
| EP-4150104-A1 | METHODS FOR SIMULTANEOUS FRAGMENTATION AND PURIFICATION OF BACTERIAL POLYSACCHARIDES | Serum Institute Of India Private Limited (IN) | 2023-03-22 | — | — | EP | disclosed |
| US-11576845-B2 | Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-14 | — | — | US | disclosed |
| US-11505769-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-11-22 | — | — | US | disclosed |
| EP-4025246-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | Serum Institute Of India Private Limited (IN) | 2022-07-13 | — | — | EP | disclosed |
| WO-2022125887-A1 | AQUEOUS DISPERSION COMPRISING ALPHA EFFECT BASED NUCLEOPHILE | PPG INDUSTRIES OHIO, INC. (US) | 2022-06-16 | — | — | WO | disclosed |
| EP-2513056-B1 | CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES | SERUM INST OF INDIA PVT LTD (IN) | 2022-05-04 | — | — | EP | disclosed |
| WO-2021229604-A1 | METHODS FOR SIMULTANEOUS FRAGMENTATION AND PURIFICATION OF BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-11-18 | — | — | WO | disclosed |
| CN-111186846-B | ITH structure silicon-aluminum molecular sieve and preparation method thereof | 中国石油大学(北京) | 2021-07-20 | — | — | CN | disclosed |
| WO-2021111814-A1 | FILM ROLL AND PRODUCTION METHOD FOR SAME | コニカミノルタ株式会社 | 2021-06-10 | — | — | WO | disclosed |
| WO-2021044436-A2 | IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | WO | disclosed |
| US-20210070890-A1 | METHOD FOR OBTAINING PURIFIED BACTERIAL POLYSACCHARIDES | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2021-03-11 | — | — | US | disclosed |
| EP-3789494-A1 | METHOD FOR OBTAINING PURIFIED BACTERIAL POLYSACCHARIDES | Serum Institute of India Private Limited (IN) | 2021-03-10 | — | — | EP | disclosed |
| US-20210032578-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2021-02-04 | — | — | US | disclosed |
| EP-3013146-B1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | 3M INNOVATIVE PROPERTIES CO (US) | 2020-11-25 | — | — | EP | disclosed |
| US-10844337-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-11-24 | — | — | US | disclosed |
| CN-111186846-A | ITH structure silicon-aluminum molecular sieve and preparation method thereof | 中国石油大学(北京) | 2020-05-22 | — | — | CN | disclosed |
| EP-3565522-A1 | METHODS OF REMOVING SPORES | 3M Innovative Properties Company (US) | 2019-11-13 | — | — | EP | disclosed |
| EP-3565411-A1 | METHODS OF REMOVING SPORES | 3M Innovative Properties Company (US) | 2019-11-13 | — | — | EP | disclosed |
| US-20190336409-A1 | METHODS OF REMOVING SPORES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-07 | — | — | US | disclosed |
| US-20190328624-A1 | METHODS OF REMOVING SPORES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-10-31 | — | — | US | disclosed |
| US-20180320116-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2018-11-08 | — | — | US | disclosed |
| US-10087405-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-10-02 | — | — | US | disclosed |
| WO-2018128965-A1 | METHODS OF REMOVING SPORES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-12 | — | — | WO | disclosed |
| WO-2018128966-A1 | METHODS OF REMOVING SPORES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-12 | — | — | WO | disclosed |
| US-9770515-B2 | Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivatives | ADVANCED PROTEOME THERAPEUTICS INC. (US) | 2017-09-26 | — | — | US | disclosed |
| EP-2859013-B1 | DIFFERENTIAL FUNCTIONALIZATION OF POLYMERS WITH AMINO-OXY REAGENTS FOR DIAGNOSTIC ASSAYS | FINA BIOSOLUTIONS LLC (US) | 2016-08-31 | — | — | EP | disclosed |
| US-20160115430-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-04-28 | — | — | US | disclosed |
| US-9259480-B2 | Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-CBT), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS LLC (US) | 2016-02-16 | — | — | US | disclosed |
| US-9254337-B2 | Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2H)-one (2-CPO), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2016-02-09 | — | — | US | disclosed |
| US-9248197-B2 | Activation of polysaccharides via the cyanylating agent, 1-cyanoimidazole (1-Cl), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2016-02-02 | — | — | US | disclosed |
| CN-102892753-B | Chemical agents for activating polysaccharides in the preparation of conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2016-01-20 | — | — | CN | disclosed |
| US-9044517-B2 | Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines | FINA BIOSOLUTIONS, LLC (US) | 2015-06-02 | — | — | US | disclosed |
| EP-2859013-A2 | DIFFERENTIAL FUNCTIONALIZATION OF POLYMERS WITH AMINO-OXY REAGENTS FOR DIAGNOSTIC ASSAYS | Fina Biosolutions LLC (US) | 2015-04-15 | — | — | EP | disclosed |
| US-20140323688-A1 | Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines | SERUM INSTITUTE OF INDIA PVT. LTD. (IN) | 2014-10-30 | — | — | US | disclosed |
| US-20140316111-A1 | Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines | SERUM INSTITUTE OF INDIA PVT. LTD. (IN) | 2014-10-23 | — | — | US | disclosed |
| US-20140316110-A1 | Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines | SERUM INSTITUTE OF INDIA PVT. LTD. (IN) | 2014-10-23 | — | — | US | disclosed |
| WO-2013188539-A2 | DIFFERENTIAL FUNCTIONALIZATION OF POLYMERS WITH AMINO-OXY REAGENTS FOR DIAGNOSTIC ASSAYS | FINA BIOSOLUTIONS, LLC (US) | 2013-12-19 | — | — | WO | disclosed |
| US-20130302877-A1 | Differential Functionalization of Polymers with Amino-Oxy Reagents for Diagnostic Assays | FINA BIOSOLUTIONS, LLC | 2013-11-14 | — | — | US | disclosed |
| US-20130216479-A1 | SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS | ADVANCED PROTEOME THERAPEUTICS, INC. | 2013-08-22 | — | — | US | disclosed |
| US-20130216479-A1 | SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS | ADVANCED PROTEOME THERAPEUTICS, INC. | 2013-08-22 | — | — | US | disclosed |
| US-20130165382-A1 | CROSSLINKING OF PROTEINS AND OTHER ENTITIES VIA CONJUGATES OF ALPHA-HALOACETOPHENONES, BENZYL HALIDES, QUINONES, AND THEIR DERIVATIVES | ADVANCED PROTEOME THERAPEUTICS INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-8431521-B2 | Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts | ADVANCED PROTEOME THERAPEUTICS, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431521-B2 | Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts | ADVANCED PROTEOME THERAPEUTICS, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-20120288518-A1 | Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines | Fina Bio Solutions ,LLC (US) | 2012-11-15 | — | — | US | disclosed |
| EP-2513056-A2 | CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES | Fina Biosolutions, LLC (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011084705-A2 | CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES | FINA BIOSOLUTIONS, LLC (US) | 2011-07-14 | — | — | WO | disclosed |
| US-20100099649-A1 | SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS | ADVANCED PROTEOME THERAPEUTICS, INC. | 2010-04-22 | — | — | US | disclosed |
| EP-0516074-B1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER CHEMIE GMBH (DE) | 1995-09-27 | — | — | EP | disclosed |
| US-5278225-A | Comprising (meth)acrylates of alcohol monomer | WACKER-CHEMIE GMBH (DE) | 1994-01-11 | — | — | US | disclosed |
| EP-0516074-A1 | Aqueous dispersions of carbonylgroup-containing copolymers, further containing aminoxy-curing agents | WACKER-CHEMIE GMBH (DE) | 1992-12-02 | — | — | EP | disclosed |
| EP-0108231-B1 | BIOCATALYST | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-02-25 | — | — | EP | disclosed |
| US-4546078-A | Polymer containing biocatalyst | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-10-08 | — | — | US | disclosed |
| EP-0108231-A1 | Biocatalyst | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-05-16 | — | — | EP | disclosed |
| EP-0108231-A1 | Biocatalyst | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099649-A1 | SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS | PTMS, OGA, AHCY | ODC1 1448/4885ADRB2 3262/4885ADRB1 2987/4885 |
| US-10844337-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-20180320116-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-11576845-B2 | Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article | ACR, CUTA, PRKDC | ODC1 2261/4885ADRB2 4443/4885ADRB1 4151/4885 |
| US-11505769-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-20240350609-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | DDOST, CD14, STT3B | ODC1 4120/4885ADRB2 4701/4885ADRB1 4792/4885 |
| US-20190336409-A1 | METHODS OF REMOVING SPORES | CUTA, ACR, PRF1 | ODC1 2631/4885ADRB2 4545/4885ADRB1 4228/4885 |
| US-10087405-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-20210032578-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-20130216479-A1 | SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS | PTMS, OGA, AHCY | ODC1 1448/4885ADRB2 3262/4885ADRB1 2987/4885 |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-20130165382-A1 | CROSSLINKING OF PROTEINS AND OTHER ENTITIES VIA CONJUGATES OF ALPHA-HALOACETOPHENONES, BENZYL HALIDES, QUINONES, AND THEIR DERIVATIVES | TBCA, HSP90AB2P, HSP90B1 | ODC1 2942/4885ADRB2 2366/4885ADRB1 2105/4885 |
| US-20230100885-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | GNPDA1, GDA, PGLS | ODC1 114/4885ADRB2 4799/4885ADRB1 4794/4885 |
| US-20190328624-A1 | METHODS OF REMOVING SPORES | CUTA, SPOUT1, POLR1C | ODC1 1057/4885ADRB2 4202/4885ADRB1 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.